Patent US2488414A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4890457A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for cryopreserving heart valves

Assignee: Artivion Inc
•
Filing: 1987-01-02
•
Granted: 1990-01-02
•
Expires: 2007-01-02
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method of freezing, storing and thawing collagen-rich tissue, such as heart valves. The method includes a freezing profile for freezing the tissue down to the temperature of liquid nitrogen with minimal tissue damage due to ice crystal formation. Heart valves cryopreserved according to the present process exhibit a high cell viability when thawed and are suitable for implanting in human patients.

Inventors

  • 👤 Robert T. McNally
  • 👤 Albert Heacox
  • 👤 Kelvin G. M. Brockbank
  • 👤 Harvey L. Bank

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 09:32
CPC Classifications
A; A01; A01N; A01N1/00; A01N1/10; A01N1/12; A01N1/122; A01N1/124; A01N1/16; A01N1/162; Y; Y10; Y10S; Y10S128/00; Y10S128/27

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 281 words
A method of cryopreserving heart valves comprising the sequential steps of: a. dissecting a heart valve from a heart; b. placing the dissected heart valve into an isotonic medium with antibiotics and a cryopreservative; c. freezing the heart valve according to a freezing schedule that will maintain cell viability comprising the sequential steps of: (1) placing the dissected heart valve in a freezing chamber, (2) lowering the temperature of said freezing chamber at a rate of approximately 0.01° C./minute to a sample temperature of approximately +4° C.; (3) lowering the temperature of said freezing chamber at a rate of approximately 1.5° C./minute to a sample temperature of approximately -3° C.; (4) lowering the temperature of said freezing chamber at a rate of approximately 95° C./minute to a chamber temperature of approximately -140° C.; (5) holding the temperature of said freezing chamber at approximately -140° C. for approximately one minute; (6) raising the temperature of said freezing chamber to approximately -100° C. at a rate of approximately 20° C./minute; (7) holding the temperature of said freezing chamber at approximately -100° C. for approximately six minutes; (8) raising the temperature of said freezing chamber to approximately -70° C. at a rate of approximately 10° C./minute; (9) raising the temperature of said freezing chamber to approximately -26° C. at a rate of approximately 20° C./minute; (10) holding the temperature of said freezing chamber at approximately -26° C. for approximately 2 minutes; and (11) lowering the temperature of said freezing chamber at a rate of 1° C./minute until the temperature of the freezing chamber is approximately -80° C.; and d. transferring the heart valve to a storage receptacle maintained at a temperature below -132° C.
Claim 2
Independent Claim 281 words
A method of cryopreserving heart valves comprising the sequential steps of: a. dissecting a heart valve from a heart; b. placing the dissected heart valve into an isotonic medium with antibiotics and a cryopreservative; c. freezing the heart valve according to a freezing schedule that will maintain cell viability comprising the sequential steps of: (1) placing the dissected heart valve in a freezing chamber, (2) lowering the temperature of said freezing chamber at a rate of approximately 0.01° C./minute to a sample temperature of approximately +4° C.; (3) lowering the temperature of said freezing chamber at a rate of approximately 1.5° C./minute to a sample temperature of approximately -3° C.; (4) lowering the temperature of said freezing chamber at a rate of approximately 95° C./minute to a chamber temperature of approximately -140° C.; (5) holding the temperature of said freezing chamber at approximately -140° C. for approximately one minute; (6) raising the temperature of said freezing chamber to approximately -100° C. at a rate of approximately 20° C./minute; (7) holding the temperature of said freezing chamber at approximately -100° C. for approximately six minutes; (8) raising the temperature of said freezing chamber to approximately -70° C. at a rate of approximately 10° C./minute; (9) raising the temperature of said freezing chamber to approximately -26° C. at a rate of approximately 20° C./minute; (10) holding the temperature of said freezing chamber at approximately -26° C. for approximately 2 minutes; and (11) lowering the temperature of said freezing chamber at a rate of 1° C./minute until the temperature of the freezing chamber is approximately -80° C.; and d. transferring the heart valve to a storage receptacle maintained at a temperature below -132° C.
Claim 3
Dependent Claim 33 words
The method of claim 1, wherein said antibiotics comprises an effective amount of a mixture of polymixin B sulfate, cefotoxin, vancomycin, and lincomycin sufficient to substantially prevent cellular toxicity and maintain antibiotic effectiveness.
Claim 4
Dependent Claim 16 words
The method of claim 1, wherein said medium is a nutrient medium for heart valve tissue.
Claim 5
Dependent Claim 10 words
The method of claim 1 wherein said cryopreservative is dimethylsulfoxide.
Claim 6
Independent Claim 101 words
A method of thawing a previously cryopreserved heart valve, comprising the sequential steps of: a. placing the frozen tissue in a sterile saline bath at a temperature of between approximately 37° C. and 42° C. for approximately 10 to 14 minutes to substantially thaw the frozen tissue; b. transferring the thawed tissue to a medium with approximately 7.5% by volume of cryopreservative for approximately 1 minute; c. transferring the thawed tissue to a medium with approximately 5% by volume of cryopreservative for approximately 1 minute; and d. transferring the thawed tissue to a medium with approximately 0% by volume of cryopreservative.
Claim 7
Independent Claim 101 words
A method of thawing a previously cryopreserved heart valve, comprising the sequential steps of: a. placing the frozen tissue in a sterile saline bath at a temperature of between approximately 37° C. and 42° C. for approximately 10 to 14 minutes to substantially thaw the frozen tissue; b. transferring the thawed tissue to a medium with approximately 7.5% by volume of cryopreservative for approximately 1 minute; c. transferring the thawed tissue to a medium with approximately 5% by volume of cryopreservative for approximately 1 minute; and d. transferring the thawed tissue to a medium with approximately 0% by volume of cryopreservative.
Claim 8
Independent Claim 380 words
A method of cryopreserving and thawing heart valves that will maintain cell viability, comprising the sequential steps of: a. dissecting a heart valve from a heart; b. placing the dissected heart valve into a isotonic medium with antibiotics and a cryopreservative; c. freezing the heart valve according to a freezing schedule comprising the sequential steps of: (1) placing the dissected heart valve in a freezing chamber, (2) lowering the temperature of said freezing chamber at a rate of approximately 0.01° C./minute to a sample temperature of approximately +4° C.; (3) lowering the temperature of said freezing chamber at a rate of approximately 1.5° C./minute to a sample temperature of approximately -3° C.; (4) lowering the temperature of said freezing chamber at a rate of approximately 95° C./minute to a chamber temperature of approximately -140° C.; (5) holding the temperature of said freezing chamber at approximately -140° C. for approximately one minute; (6) raising the temperature of said freezing chamber to approximately -100° C. at a rate of approximately 20° C./minute; (7) holding the temperature of said freezing chamber to approximately -100° C. for approximately six minutes; (8) raising the temperature of said freezing chamber to approximately -70° C. at a rate of approximately 10° C./minute; (9) raising the temperature of said freezing chamber to approximately -26° C. at a rate of approximately 20° C./minute; (10) holding the temperature of said freezing chamber to approximately -26° C. for approximately 2 minutes; and (11) lowering the temperature of said freezing chamber at a rate of 1° C./minute until the temperature of the freezing chamber is approximately -80° C.; (d) transferring the heart valve to a storage receptacle maintained at a temperature below -132° C.; and (e) thawing the frozen tissue by the sequential steps of: (1) placing the frozen tissue in a sterile saline bath at a temperature of between approximately 37° C. and 42° C. for approximately 10 to 14 minutes to substantially thaw the frozen tissue; (2) transferring the thawed tissue to a medium with approximately 7.5% by volume of cryopreservative for approximately 1 minute; (3) transferring the thawed tissue to a medium with approximately 5% by volume of cryopreservative for approximately 1 minute; and (4) transferring the thawed tissue to a medium with approximately 0% by volume of cryopreservative.
Claim 9
Independent Claim 380 words
A method of cryopreserving and thawing heart valves that will maintain cell viability, comprising the sequential steps of: a. dissecting a heart valve from a heart; b. placing the dissected heart valve into a isotonic medium with antibiotics and a cryopreservative; c. freezing the heart valve according to a freezing schedule comprising the sequential steps of: (1) placing the dissected heart valve in a freezing chamber, (2) lowering the temperature of said freezing chamber at a rate of approximately 0.01° C./minute to a sample temperature of approximately +4° C.; (3) lowering the temperature of said freezing chamber at a rate of approximately 1.5° C./minute to a sample temperature of approximately -3° C.; (4) lowering the temperature of said freezing chamber at a rate of approximately 95° C./minute to a chamber temperature of approximately -140° C.; (5) holding the temperature of said freezing chamber at approximately -140° C. for approximately one minute; (6) raising the temperature of said freezing chamber to approximately -100° C. at a rate of approximately 20° C./minute; (7) holding the temperature of said freezing chamber to approximately -100° C. for approximately six minutes; (8) raising the temperature of said freezing chamber to approximately -70° C. at a rate of approximately 10° C./minute; (9) raising the temperature of said freezing chamber to approximately -26° C. at a rate of approximately 20° C./minute; (10) holding the temperature of said freezing chamber to approximately -26° C. for approximately 2 minutes; and (11) lowering the temperature of said freezing chamber at a rate of 1° C./minute until the temperature of the freezing chamber is approximately -80° C.; (d) transferring the heart valve to a storage receptacle maintained at a temperature below -132° C.; and (e) thawing the frozen tissue by the sequential steps of: (1) placing the frozen tissue in a sterile saline bath at a temperature of between approximately 37° C. and 42° C. for approximately 10 to 14 minutes to substantially thaw the frozen tissue; (2) transferring the thawed tissue to a medium with approximately 7.5% by volume of cryopreservative for approximately 1 minute; (3) transferring the thawed tissue to a medium with approximately 5% by volume of cryopreservative for approximately 1 minute; and (4) transferring the thawed tissue to a medium with approximately 0% by volume of cryopreservative.
Claim 10
Dependent Claim 34 words
The method of claim 6, wherein said antibiotics comprises an antibiotically effective amount of a mixture of polymixing B sulfate, cefotoxin, vancomycin, and lincomycin sufficient to substantially prevent cellular toxicity and maintain antibiotic effectiveness.
Claim 11
Dependent Claim 16 words
The method of claim 6, wherein said medium is a nutrient medium for heart valve tissue.
Claim 12
Dependent Claim 10 words
The method of claim 6, wherein said cryopreservative is dimethylsulfoxide.
Claim 13
Dependent Claim 33 words
The method of claim 6, further comprising the additional step, immediately following step e(3), of transferring the frozen tissue to a medium with approximately 2.5% by volume of cryopreservative for approximately 1 minute.

References Cited (Backward Citations)

US3303662A Cited
US4008754A Cited
US4134359A Cited
US4464337A Cited
US4455842A Cited
US4429542A Cited
US4388814A Cited
US4537034A Cited
US4559298A Cited
US4423600A Cited
US4597266A Cited
US4688387A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-01-01 1993-07-03 1994-01-02 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-01-01 1997-07-03 1998-01-02 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-01-01 2001-07-03 2002-01-02 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag